Our Mission: Improving and Extending the Lives of Patients with Cancer
  
 
 About Celator®   |   Products   |   CombiPlex®   |   Publications   |   News & Events   |   Contact   |   Home
  General       CPX-351       CPX-1       CPX-571       Nanoparticle Prodrug Delivery       Other
 

Publications: Other

Manuscripts

  Role of copper gluconate/triethanolamine in irinotecan encapsulation inside the liposomes | Dicko et al, Int J Pharm 2007 Jun 7; 337(1-2): 219-228
   
  In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine | Webb et al, Eur J Pharm Biopharm 2007 Mar; 65(3): 289-299

 

 

 

 


CombiPlex® technology is a novel approach that identifies molar ratios of drugs that will deliver a synergistic benefit and locks the desired ratio in a nano-scale drug delivery vehicle that delivers and maintains the ratio in patients with the goal of improving clinical outcomes.

 

 

 

 

 

  
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.